TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
STRO

Sutro Biopharma

Healthcare · Biotechnology

15.30$ -0.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Sutro Biopharma (STRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 174 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet STRO
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
69 41 223 156 394 341 407 471 387 174
50 26 210 129 378 219 353 422 343 151
12 22 125 5.0 206 30 47 69 190 58
48 22 204 118 368 198 334 376 317 141
0.6 1.6 2.5 6.3 5.6 12 7.1 36 8.6 4.0
0.0 0.0 -12 0.0
19 14 11 9.6 13 52 51
160 150 92 59 62 89 190 321 343 306
50 32 36 33 30 42 67 94 132 75
3.2 15 4.7 1.0 8.8 10 22 10 7.5 7.8
3.4 2.9 3.1 5.6 5.5 6.0 4.8 9.4 10 7.6
1.2 1.7 10 8.9 25 16 3.8
-91 -109 132 98 332 253 217 150 45 -132
-95 -115 -150 -196 -228 -333 -453 -559 -787 -978
0.0 7.0 2.3 2.3 33 4.6 5.1 6.0 7.7 8.5

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?